IceCure Medical has issued bonds worth US$5.7 million
IceCure Medical Ltd. has completed a fundraising to refinance and develop the company.
IceCure is an Israeli medical device company that has developed technology to eliminate benign and cancerous tumors in the breast and other parts of the body by freezing the tumor during treatment in a clinic and without surgery, using the ProSense system developed at the Elisha Private Hospital in Haifa.
Oaklins’ team in Israel advised IceCure Medical Ltd. and acted as the leader of the distributors’ consortium.
Talk to the deal team
PrincipalTel Aviv, Israel
PartnerTel Aviv, Israel
SupportTel Aviv, Israel
Maginnis Orthodontics has been acquired by Smile Doctors
Maginnis Orthodontics, Inc. has been sold to Smile Doctors, LLC.Learn more
Pridiktiv has been acquired by Corilus
The shareholders and founders of Pridiktiv NV have sold the company to Corilus.Learn more
Global Media Santé has been acquired by SFP Expansion
Global Media Santé’s CEO, Alain Trébucq, and Apax Partners have sold the company to SFP Expansion Group.Learn more